Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Bioventus Inc. (BVS) Misses Q2 EPS by 6c; Offers FY22 Guidance
August 11, 2022 7:09 AM EDTBioventus Inc. (NASDAQ: BVS) reported Q2 EPS of $0.10, $0.06 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $138.33 million.
GUIDANCE:
Bioventus Inc. sees FY2022 EPS of $0.47-$0.57, versus the consensus of $0.65.... More
